amphotericin-b and Vulvovaginitis

The antifungal effects of 2-phenylethanol are clearly visible through its intervention in Candida morphogenesis. Chronic and recurrent vulvovaginitis, however, does not respond to this standard experimental therapy; therefore, the study presented in this article investigated the effect of common antifungal drugs (amphotericin B [AMB], fluconazole [FLU], and itraconazole [ITC]), in combination with 2-phenylethanol, on the Candida species isolated from cases of chronic and recurrent vulvovaginitis, thereby allowing the recommendation of a more appropriate treatment option. Forty isolates from patients with chronic and recurrent vaginal candidiasis were investigated in this experimental study. The specimens were examined by direct microscopy, culturing, and PCR to identify the species. The antifungal effects of 2-phenylethanol and conventional drugs, both alone and in combination, were determined in duplicate. Finally, the findings were analyzed. In this study, 40 strains of Candida species were identified, whose agents were Candida albicans (95%) and Candida africana (5%). After 48 h, the minimum inhibitory concentration (MIC) range of the 2-phenylethanol was 800-3,200 μg/mL. Also, in the final study on the MIC levels of common antifungal drugs, AMB (0.42 μg/mL) had the lowest MIC, FLU (40.51 μg/mL) had the highest MIC, and the combination of ITC and 2-phenylethanol had the lowest fractional inhibitory concentration index (FICI) of any of the combinations (FICI range, 0.26-1.03). Combining FLU and ITC with 2-phenylethanol can effectively increase their antifungal effect.

Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Chronic Disease; Dose-Response Relationship, Drug; Female; Fluconazole; Humans; Itraconazole; Middle Aged; Phenylethyl Alcohol; Vulvovaginitis

Topics: Adrenal Cortex Hormones; Amphotericin B; Candidiasis; Candidiasis, Cutaneous; Candidiasis, Oral; Female; Fingers; Glossitis; Humans; Infant, Newborn; Lip; Male; Metabolic Diseases; Middle Aged; Nutrition Disorders; Paronychia; Pregnancy; Vulvovaginitis

Topics: Amphotericin B; Candidiasis, Vulvovaginal; Female; Humans; Mycoses; Pregnancy; Pregnancy Complications, Infectious; Vulvovaginitis

Topics: Amphotericin B; Anti-Bacterial Agents; Female; Humans; Protein Synthesis Inhibitors; Tetracycline; Trichomonas Vaginitis; Vaginitis; Vulvovaginitis

Topics: Amphotericin B; Candidiasis, Vulvovaginal; Female; Humans; Protein Synthesis Inhibitors; Tetracycline; Trichomonas Vaginitis; Vaginitis; Vulvovaginitis